Eric Van Cutsem Selected Research

Eric Van Cutsem Research Topics

Disease

132	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 04/2002
129	Neoplasms (Cancer) 05/2024 - 07/2004
49	Adenocarcinoma 05/2024 - 08/2005
47	Disease Progression 12/2023 - 01/2004
39	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2002
30	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2007
29	Colonic Neoplasms (Colon Cancer) 11/2022 - 04/2002
22	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 03/2004
21	Neutropenia 01/2023 - 01/2004
20	Fatigue 10/2023 - 02/2011
19	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 01/2010
16	Rectal Neoplasms (Rectal Cancer) 09/2022 - 02/2005
14	Hypertension (High Blood Pressure) 01/2023 - 09/2009
13	Microsatellite Instability 01/2024 - 09/2009
12	Diarrhea 01/2023 - 01/2007
9	Nausea 12/2023 - 01/2004
8	Stomatitis 01/2018 - 01/2004
7	Vomiting 01/2023 - 01/2007
7	Exanthema (Rash) 02/2015 - 10/2007
6	Thrombocytopenia (Thrombopenia) 10/2021 - 04/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2019 - 01/2005
5	Abdominal Pain (Pain, Abdominal) 04/2023 - 03/2011
5	Anemia 01/2020 - 02/2011
5	Carcinoma (Carcinomatosis) 10/2018 - 12/2004
5	Febrile Neutropenia 01/2017 - 01/2013
5	Carcinoid Tumor (Carcinoid) 12/2015 - 01/2004
4	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2013
4	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 08/2010
4	Cholangiocarcinoma 09/2023 - 01/2018
4	Hand-Foot Syndrome 01/2023 - 01/2004
4	Inflammation (Inflammations) 01/2022 - 01/2018
3	Pneumonia (Pneumonitis) 12/2023 - 01/2017
3	Esophageal Squamous Cell Carcinoma 10/2023 - 10/2022
3	Asthenia 01/2023 - 02/2011
3	Heart Arrest (Cardiac Arrest) 01/2023 - 01/2019
3	Hemorrhage 01/2023 - 05/2011
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2022 - 09/2011

Drug/Important Bio-Agent (IBA)

53	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 04/2002
36	ErbB Receptors (EGF Receptor)IBA 12/2023 - 07/2004
36	Cetuximab (Erbitux)FDA Link 10/2023 - 07/2004
35	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 04/2002
34	Leucovorin (Folinic Acid)FDA Link 01/2023 - 04/2002
33	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 04/2002
31	Bevacizumab (Avastin)FDA Link 11/2023 - 12/2004
31	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2004
23	Gemcitabine FDA Link 10/2023 - 03/2004
22	Capecitabine (Xeloda)FDA Link 01/2023 - 04/2002
20	Monoclonal AntibodiesIBA 01/2023 - 08/2005
18	Panitumumab (Vectibix)FDA Link 12/2023 - 01/2007
17	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 08/2005
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2007
16	pembrolizumabIBA 12/2023 - 03/2019
13	trifluridine tipiracil drug combinationIBA 02/2024 - 05/2015
10	Trastuzumab (Herceptin)FDA Link 12/2023 - 08/2010
10	regorafenibIBA 01/2023 - 01/2013
10	RamucirumabIBA 10/2021 - 10/2014
10	Everolimus FDA Link 01/2018 - 01/2010
9	Docetaxel (Taxotere)FDA Link 10/2022 - 01/2004
9	afliberceptIBA 01/2020 - 10/2012
8	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 04/2008
8	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 10/2014
7	PlatinumIBA 12/2023 - 04/2012
7	130-nm albumin-bound paclitaxelIBA 10/2023 - 10/2013
7	Octreotide (Sandostatin)FDA LinkGeneric 06/2023 - 04/2010
7	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 12/2017
6	NivolumabIBA 05/2024 - 10/2018
6	binimetinibIBA 04/2024 - 10/2019
6	Peptide Receptors (Peptide Receptor)IBA 01/2022 - 01/2013
6	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2013
6	Angiogenesis InhibitorsIBA 01/2019 - 01/2011
6	XELOXIBA 11/2015 - 06/2004
5	Immune Checkpoint InhibitorsIBA 04/2024 - 08/2021
5	encorafenibIBA 10/2023 - 10/2019
5	Proteins (Proteins, Gene)FDA Link 04/2023 - 08/2010
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 03/2011
5	LigandsIBA 01/2022 - 10/2009
5	thiamine triphosphorate (TTP)IBA 01/2022 - 06/2004
5	Sodium Glutamate (Accent)IBA 11/2021 - 07/2013
5	ParaffinIBA 04/2014 - 04/2007
5	Tyrosine Kinase InhibitorsIBA 10/2012 - 08/2005
4	napabucasinIBA 04/2023 - 04/2019
4	human ERBB2 proteinIBA 01/2023 - 08/2010
4	Epidermal Growth Factor (EGF)IBA 01/2023 - 04/2002
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2020 - 01/2015
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 02/2013
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2012 - 08/2005
4	AntibodiesIBA 12/2010 - 05/2007
3	IpilimumabIBA 04/2024 - 10/2018
3	Antineoplastic Agents (Antineoplastics)IBA 02/2024 - 02/2017
3	tislelizumabIBA 10/2023 - 10/2022
3	Lipase (Acid Lipase)FDA Link 01/2023 - 06/2015

Therapy/Procedure

112	Therapeutics 12/2023 - 04/2002
96	Drug Therapy (Chemotherapy) 05/2024 - 01/2002
14	Adjuvant Chemotherapy 12/2023 - 08/2004
8	Chemoradiotherapy 09/2022 - 01/2002
8	Radiotherapy 08/2021 - 12/2004
7	Neoadjuvant Therapy 09/2022 - 03/2004
4	Microspheres (Microsphere) 08/2020 - 08/2010
3	Colectomy 04/2022 - 09/2011
3	Cytoreduction Surgical Procedures 01/2022 - 07/2012